Drug
Fostemsavir
Fostemsavir: highest development phase Phase 3, developed by ViiV Healthcare. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- ViiV Healthcare
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fostemsavir NCT07393659 | Phase 3 | HIV Infections |
Latest
No recent events.
Follow Fostemsavir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.